Sport with Tibo token, a French fitness or name community coin. This feed follows workout challenges, Tibo InShape‑inspired NFTs, and the athletic Tibo energy.
Our Johnson & Johnson (NYSE:JNJ) 24/7 Wall St. price target lands at $261.72, pointing to 11.28% upside from the current price of $235.18. Our recommendation is
2026/06/21
AbbVie is nearing a $10.9 billion cash deal for Apogee Therapeutics, a roughly 60% premium, in its largest acquisition since the 2019 Allergen deal.
Avert your eyes! My Sunday morning look at incompetency, corruption and policy failures: • The World’s Leading Deepfake Expert No Longer Trusts His Own Eyes: NYT
VERAXA Biotech releases new in vitro data for its BiTAC-ADC platform, showing tumor-specific killing of breast cancer cells with reduced toxicity. The company seeks
2026/06/19
Incyte (INCY) stock dropped 0.78% to $98.22 as Japan approved Minjuvi for relapsed DLBCL treatment, marking the drug's second approval in the country. The post
TLDR INCY fell 0.78% to $98.22 as Japan approved Minjuvi for relapsed DLBCL use. Japan cleared Minjuvi with lenalidomide for adults with relapsed DLBCL care. L-
Infant Mortality Drops To All-Time Low In United States Infant mortality has dropped to the lowest level ever recorded in the United States, according
This week was not an exceptionally busy one for large funding deals, though we saw sizable rounds in a lively mix of sectors ranging from AI to fintech to quantum
VERAXA Biotech announces in vitro proof-of-concept for BiTAC-ADC platform, targeting breast cancer with tumor-restricted activation. Data shows dose-dependent killing
2026/06/18
When you think of probiotics, think of fermented foods like sauerkraut.
2023/04/23